CVE-2020-14486 — MEDIUM (6.3)

Vulnerability Description

An attacker may bypass permission/authorization checks in OpenClinic GA 5.09.02 and 5.89.05b by ignoring the redirect of a permission failure, which may allow unauthorized execution of commands.

CVSS Score

6.3

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

LOW

Integrity

LOW

Availability

LOW

Affected Products

Vendor	Product	Versions
Openclinic Ga Project	Openclinic Ga	5.09.02

Related Weaknesses (CWE)

CWE-285 CWE-863

References

https://us-cert.cisa.gov/ics/advisories/ICSMA-20-184-01Third Party AdvisoryUS Government Resource
https://us-cert.cisa.gov/ics/advisories/ICSMA-20-184-01Third Party AdvisoryUS Government Resource

FAQ

What is CVE-2020-14486?

CVE-2020-14486 is a vulnerability with a CVSS score of 6.3 (MEDIUM). An attacker may bypass permission/authorization checks in OpenClinic GA 5.09.02 and 5.89.05b by ignoring the redirect of a permission failure, which may allow unauthorized execution of commands.

How severe is CVE-2020-14486?

CVE-2020-14486 has been rated MEDIUM with a CVSS base score of 6.3/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2020-14486?

Check the references section above for vendor advisories and patch information. Affected products include: Openclinic Ga Project Openclinic Ga.